These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31262983)

  • 1. Taming the Beast: Interplay between Gut Small Molecules and Enteric Pathogens.
    Kumar A; Ellermann M; Sperandio V
    Infect Immun; 2019 Sep; 87(9):. PubMed ID: 31262983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between the microbiota and pathogenic bacteria in the gut.
    Bäumler AJ; Sperandio V
    Nature; 2016 Jul; 535(7610):85-93. PubMed ID: 27383983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation.
    Ponziani FR; Zocco MA; D'Aversa F; Pompili M; Gasbarrini A
    World J Gastroenterol; 2017 Jul; 23(25):4491-4499. PubMed ID: 28740337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
    Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
    mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibiotics for treatment of inflammatory bowel disease.
    Nitzan O; Elias M; Peretz A; Saliba W
    World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection.
    Ducarmon QR; Zwittink RD; Hornung BVH; van Schaik W; Young VB; Kuijper EJ
    Microbiol Mol Biol Rev; 2019 Aug; 83(3):. PubMed ID: 31167904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the Gut Ecosystem by Antibiotics.
    Yoon MY; Yoon SS
    Yonsei Med J; 2018 Jan; 59(1):4-12. PubMed ID: 29214770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
    Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
    Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole Signaling at the Host-Microbiota-Pathogen Interface.
    Kumar A; Sperandio V
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile.
    Schubert AM; Sinani H; Schloss PD
    mBio; 2015 Jul; 6(4):e00974. PubMed ID: 26173701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection.
    Khan I; Bai Y; Zha L; Ullah N; Ullah H; Shah SRH; Sun H; Zhang C
    Front Cell Infect Microbiol; 2021; 11():716299. PubMed ID: 35004340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens.
    Pamer EG
    Science; 2016 Apr; 352(6285):535-8. PubMed ID: 27126035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: the antimicrobial effects of rifaximin on the gut microbiota.
    DuPont HL
    Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():3-10. PubMed ID: 26618921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate affects bacterial virulence: a new perspective on preventing enteric bacterial pathogen invasion.
    Liu X; Tang H; Huang X; Xu M
    Future Microbiol; 2024 Jan; 19():73-84. PubMed ID: 38085176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
    Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota-mediated colonization resistance against intestinal pathogens.
    Buffie CG; Pamer EG
    Nat Rev Immunol; 2013 Nov; 13(11):790-801. PubMed ID: 24096337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commensal E. coli rapidly transfer antibiotic resistance genes to human intestinal microbiota in the Mucosal Simulator of the Human Intestinal Microbial Ecosystem (M-SHIME).
    Lambrecht E; Van Coillie E; Van Meervenne E; Boon N; Heyndrickx M; Van de Wiele T
    Int J Food Microbiol; 2019 Dec; 311():108357. PubMed ID: 31536878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlortetracycline Enhances Tonsil Colonization and Fecal Shedding of Multidrug-Resistant
    Holman DB; Bearson BL; Allen HK; Shippy DC; Loving CL; Kerr BJ; Bearson SMD; Brunelle BW
    Appl Environ Microbiol; 2019 Feb; 85(4):. PubMed ID: 30530706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.